NCT02638194

Brief Summary

The primary purpose of this study is to examine the health effects of mainstream and secondhand hookah (i.e. water pipe) smoke on pulmonary and cardiovascular functions as well as serum levels of inflammatory biomarkers. Investigators would like to demonstrate that inhalation of both mainstream and secondhand smoke generated by hookah produces adverse pulmonary and cardiovascular effects and alterations in serum levels of inflammatory biomarkers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 23, 2015

Completed
Last Updated

December 23, 2015

Status Verified

December 1, 2015

Enrollment Period

3 months

First QC Date

December 11, 2015

Last Update Submit

December 18, 2015

Conditions

Keywords

Chronic Obstructive Pulmonary Disease (COPD)smokingsecondhand smoke

Outcome Measures

Primary Outcomes (16)

  • Changes in exhaled carbon dioxide measured by pulmonary function measure using a portable spirometer

    subsequently after 2 hours of hookah smoking or smoke exposure and 24 hours after participants' visit hookah and wine bars.

  • Changes in Heart Rate measured by a portable monitor worn during encounters

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in blood oxygenation levels measured by a pulse oximeter

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of tobacco-related carcinogenic metabolite cotinine in saliva samples

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker endothelin

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker IL-10

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker IL-8

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker IL-6

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker CRP

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker IL-1a

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker IFN-g

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker TNF-a

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker GM-CSF

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker E-selectin

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker thrombomodulin

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

  • Changes in measure of blood inflammatory marker vWF

    subsequently after 2 hours of hookah smoking and 24 hours after participants' visit hookah and wine bars.

Secondary Outcomes (1)

  • Changes in Air Quality measured by an aethelometer

    2 hours spent at hookah bar

Study Arms (2)

Hookah Smoking Group

ACTIVE COMPARATOR

10 participants will smoke tobacco hookah for 2 hours

Other: Active smoking of Tobacco Hookah for 2 hoursOther: Visit a win bar

Hookah Secondhand Smoke Group

ACTIVE COMPARATOR

10 individuals will be exposed to secondhand hookah tobacco smoke for 2 hours

Other: Exposure to tobacco hookah second hand smokeOther: Visit a win bar

Interventions

Hookah Secondhand Smoke Group

Participants will visit a wine bar for food and/or drinks

Hookah Secondhand Smoke GroupHookah Smoking Group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Competent adult English speaking subjects
  • Have used hookah in the past

You may not qualify if:

  • Age \<21
  • Pregnancy
  • Current cigarette smokers
  • Has pulmonary disease, such as asthma or Chronic Obstructive Pulmonary Disease (COPD)
  • Subjects are unable to give voluntary informed consent because they are non English speaking, are unable to read or write, or any other impediments that prohibits giving written informed consent
  • Recent nasal surgery (within 6 months)
  • History of bleeding or other blood related disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveSmoking

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Michael Weitzman, MD

    NYU Langone Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2015

First Posted

December 23, 2015

Study Start

July 1, 2014

Primary Completion

October 1, 2014

Study Completion

September 1, 2015

Last Updated

December 23, 2015

Record last verified: 2015-12

Data Sharing

IPD Sharing
Will not share

Locations